Merck KGaA, Pfizer's Bavencio set to seal bladder cancer approval after confirmatory trial scores
Bavencio could use the win.
More than two years after its makers — Germany’s Merck KGaA and Pfizer — secured FDA approval for a form of bladder …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
